Jerkku Thomas, Mohammed Waleed Mahmood, Kapetanios Dimitrios, Czihal Michael, Tsilimparis Nikolaos, Banafsche Ramin
Department of Vascular Surgery, Ludwig-Maximilian University Hospital, Munich, Germany.
Section of Angiology, Ludwig-Maximilian University Hospital, Munich, Germany.
Ann Vasc Surg. 2020 Jan;62:195-205. doi: 10.1016/j.avsg.2019.06.013. Epub 2019 Aug 23.
In some cases of complex aortoiliac endovascular repair, the hypogastric landing zone is suboptimal or even insufficient. This study aimed at the technical feasibility and at the outcome of iliac branch device (IBD) deployment with extension of the IBD into the superior gluteal artery (SGA).
This study involves a retrospective analysis of a prospectively maintained single-center cohort of patients with implantation of IBD for aortoiliac and postdissection aneurysms. The IBD cohort with landing zones in the hypogastric main trunk (IIA IBD) was compared with the IBD cohort with landing zones in the SGA (SGA IBD). The main outcome parameters were primary technical success, patency of the hypogastric branch, and freedom from IBD-specific secondary interventions within 30 days. Other outcomes of interest were long-term patency and freedom from buttock claudication, as well as the incidence of endoleaks. Group comparisons were made by univariate significance tests, and freedom from reintervention was analyzed with the Kaplan-Meier-method.
From January 2015 to October 2017, a total of 46 IBDs were implanted in 40 patients (39 male; mean age, 71.9 ± 9.1 years). Nineteen of 46 (41.3%) IBDs were extended with at least one bridging stent graft into the SGA because of aneurysmal or short internal iliac artery (IIA). Technical success was achieved in 97.8% (96.3% for IIA IBD vs. 100% for SGA IBD, P = 0.163), and the primary ipsilateral limb patency rate was 100% within 30 days after the procedure. During a mean follow-up period of 19.8 ± 10.0 months (24.7 ± 10.8 for IIA IBD vs. 25.1 ± 9.8 for SGA IBD, P = 0.461), 11.1% IBDs in the IIA IBD group and 15.8% IBDs in the SGA IBD group needed secondary interventions (P = 0.33). Follow-up revealed no patients suffering from persistent buttock claudication or erectile dysfunction. One patient in the SGA IBD group died at late follow-up from a non-aneurysm-related cause.
Extension of IBD into the SGA is a technically feasible and safe maneuver in the treatment of aortoiliac aneurysms with outcomes comparable to those when IBDs extend to the main trunk of the hypogastric artery.
在一些复杂的主-髂动脉血管腔内修复病例中,下腹动脉着陆区不理想甚至不足。本研究旨在探讨髂支装置(IBD)延伸至臀上动脉(SGA)进行部署的技术可行性及结果。
本研究对前瞻性维护的单中心队列中接受IBD植入治疗主-髂动脉及夹层后动脉瘤的患者进行回顾性分析。将着陆区位于下腹动脉主干的IBD队列(IIA IBD)与着陆区位于SGA的IBD队列(SGA IBD)进行比较。主要结局参数为初次技术成功率、下腹动脉分支通畅率以及30天内无IBD特异性二次干预。其他感兴趣的结局包括长期通畅率、无臀部间歇性跛行以及内漏发生率。通过单因素显著性检验进行组间比较,并用Kaplan-Meier法分析无再次干预情况。
2015年1月至2017年10月,40例患者(39例男性;平均年龄71.9±9.1岁)共植入46枚IBD。46枚IBD中有19枚(41.3%)因动脉瘤或髂内动脉(IIA)短而至少用一枚桥接支架延伸至SGA。技术成功率为97.8%(IIA IBD为96.3%,SGA IBD为100%,P = 0.163),术后30天内同侧肢体初次通畅率为100%。在平均随访期19.8±10.0个月(IIA IBD为24.7±10.8个月,SGA IBD为25.1±9.8个月,P = 0.461)期间,IIA IBD组11.1%的IBD和SGA IBD组15.8%的IBD需要二次干预(P = 0.33)。随访发现无患者出现持续性臀部间歇性跛行或勃起功能障碍。SGA IBD组有1例患者在随访后期死于非动脉瘤相关原因。
将IBD延伸至SGA在治疗主-髂动脉动脉瘤方面是一种技术可行且安全的操作,其结果与IBD延伸至下腹动脉主干时相当。